Pagano R E, Martin O C, Schroit A J, Struck D K
Biochemistry. 1981 Aug 18;20(17):4920-7. doi: 10.1021/bi00520a018.
A method is presented for generating artificial lipid vesicles bearing an asymmetric distribution of either of the fluorescent lipid analogues 1-acyl-2-[6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]caproyl]phosphatidylcholine or 1-acyl-2-[12[(7-nitro-2,1,3-benzoxadiazol-4-yl]amino]dodecanoyl]-phosphatidylcholine, in which the fluorescent lipid is located predominantly in either the outer or inner leaflet of the vesicle bilayer. The procedure is based on the observation that these lipid analogues undergo rapid spontaneous transfer (exchange) between vesicle populations [Nichols, J. W., & Pagano, R. E. (1981) Biochemistry 20, 2783-2789]. When an excess of nonfluorescent acceptor vesicles is mixed with small unilamellar vesicles containing 5 mol % fluorescent lipid, approximately 50% of the fluorescent lipid is transferred to the acceptor vesicles, whereas if fluorescent multilamellar vesicles are used, only approximately 10% of the analogues is available for transfer. These fractions of fluorescent lipid available for intervesicular transfer correspond closely to the amount of phospholipid residing in the outermost leaflet of the donor vesicles, suggesting that only fluorescent lipids present in the outer surface of the vesicles can spontaneously transfer between vesicles populations. Evidence demonstrating that the movement of the fluorescent lipid between vesicle population is the result of a net transfer process rather than lipid exchange is also presented. A novel assay based on resonance energy transfer is described for determining the size of the exchangeable fluorescent lipid pool, a measure of the degree of asymmetry of these preparations. Finally, for demonstration of the usefulness of asymmetric vesicles in distinguishing various pathways of vesicle-cell association, preliminary results are presented on their interactions with Chinese hamster fibroblasts in vitro.
本文介绍了一种生成人工脂质囊泡的方法,该脂质囊泡带有荧光脂质类似物1-酰基-2-[6-[(7-硝基-2,1,3-苯并恶二唑-4-基)氨基]己酰基]磷脂酰胆碱或1-酰基-2-[12-[(7-硝基-2,1,3-苯并恶二唑-4-基)氨基]十二烷酰基]-磷脂酰胆碱的不对称分布,其中荧光脂质主要位于囊泡双层的外层或内层。该方法基于这样的观察结果:这些脂质类似物在囊泡群体之间会发生快速的自发转移(交换)[尼科尔斯,J.W.,& 帕加诺,R.E.(1981年)《生物化学》20,2783 - 2789]。当过量的非荧光受体囊泡与含有5摩尔%荧光脂质的小单层囊泡混合时,大约50%的荧光脂质会转移到受体囊泡中,而如果使用荧光多层囊泡,只有大约10%的类似物可用于转移。这些可用于囊泡间转移的荧光脂质部分与供体囊泡最外层小叶中存在的磷脂量密切对应,这表明只有存在于囊泡外表面的荧光脂质才能在囊泡群体之间自发转移。还提供了证据证明荧光脂质在囊泡群体之间的移动是净转移过程的结果而非脂质交换。描述了一种基于共振能量转移的新型测定方法,用于确定可交换荧光脂质池的大小,这是这些制剂不对称程度的一种度量。最后,为了证明不对称囊泡在区分囊泡 - 细胞结合的各种途径方面的有用性,展示了它们与中国仓鼠成纤维细胞体外相互作用的初步结果。